Pharmaceutical formulation of the sodium salt of telmisartan

Details for Australian Patent Application No. 2004233581 (hide)

Owner Boehringer Ingelheim International GmbH

Inventors Kohlrausch, Anja

Agent Davies Collison Cave

Pub. Number AU-B-2004233581

PCT Pub. Number WO2004/096215

Priority 103 19 450.9 30.04.03 DE

Filing date 27 April 2004

Wipo publication date 11 November 2004

Acceptance publication date 22 April 2010

International Classifications

A61K 31/4184 (2006.01)

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 31/39 (2006.01) - having oxygen atoms in the same ring

A61K 31/41 (2006.01) - having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole

Event Publications

8 December 2005 PCT application entered the National Phase

  PCT publication WO2004/096215 Priority application(s): WO2004/096215

22 April 2010 Application Accepted

  Published as AU-B-2004233581

19 August 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004233582-Pharmaceutical compositon comprising a cathepsin S inhibitor and an opioid

2004233577-Diazabicyclononene derivatives